Medical therapy for inflammatory bowel disease.

  title={Medical therapy for inflammatory bowel disease.},
  author={Rachel Stein and S B Hanauer},
  journal={Gastroenterology clinics of North America},
  volume={28 2},
CD and UC represent a spectrum of chronic IBD that present in protean ways and are accompanied by a variety of systemic sequelae. Sulfasalazine and the newer 5-aminosalicylates are important in the management of mild-to-moderate disease, whereas corticosteroids remain the primary therapy for most patients with moderate-to-severe disease (Tables 2-5). The toxicities associated with long-term steroid therapy, combined with their ineffectiveness as maintenance medications, have led to increased… CONTINUE READING